Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Jounce Therapeutics, Inc.
About JNCE
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It is engaged in the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Its pipeline is focused on product candidates to address PD-(L)1-inhibitor resistant and PD-(L)1 inhibitor sensitive tumors. Its program, JTX-8064, is a tumor-associated macrophage candidate from its Translational Science platform. JTX-8064 is a monoclonal antibody that binds to Leukocyte Immunoglobulin Like Receptor B2, (LILRB2), which is a cell surface receptor expressed on macrophages and other myeloid cells. JTX-1484 is a monoclonal antibody designed to block human Leukocyte Immunoglobulin Like Receptor B4, (LILRB4) on various myeloid cells. Its product candidate, vopratelimab, is a monoclonal antibody that binds to and activates T cell CO-Stimulator (ICOS). It also develops JTX-1484 and JTX-2134 product candidates.
Find out what a historical investment in Jounce Therapeutics, Inc. would be worth today using our JNCE stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy JNCE shares in Australia?
Buying JNCE shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Jounce Therapeutics, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in JNCE
What is the ticker symbol of Jounce Therapeutics, Inc.?
The ticker symbol for Jounce Therapeutics, Inc. is JNCE.
How much is one share of JNCE?
One share of JNCE is valued at $1.92 as of 16 May 2026.
What is the market capitalisation of Jounce Therapeutics, Inc. JNCE?
As of 16 May 2026 Jounce Therapeutics, Inc. has a market cap of -.
What is the 52-week high for Jounce Therapeutics, Inc. stock?
The Jounce Therapeutics, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Jounce Therapeutics, Inc. stock?
The Jounce Therapeutics, Inc. 52-week low stock price is $NaN.
Can I buy JNCE shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy JNCE shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in JNCE on Stake
- Buy JNCE from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of JNCE from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
JNCE related stocks